Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á, del Amo J, Esteban LM, Ars E, Hernández C, Planas J, Arruza A, Llarena R, Palou J, Herranz F, Raventós CX, Tejedor D, Artieda M, Simon L, Martínez A, Carceller E, Suárez M, Allué M, Sanz G, Morote J. Borque Á, et al. Among authors: esteban lm. BJU Int. 2013 Apr;111(4):549-58. doi: 10.1111/j.1464-410X.2012.11333.x. Epub 2012 Jul 3. BJU Int. 2013. PMID: 22759231
The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry.
Borque-Fernando Á, Rubio-Briones J, Esteban LM, Collado-Serra A, Pallás-Costa Y, López-González PÁ, Huguet-Pérez J, Sanz-Vélez JI, Gil-Fabra JM, Gómez-Gómez E, Quicios-Dorado C, Fumadó L, Martínez-Breijo S, Soto-Villalba J. Borque-Fernando Á, et al. Among authors: esteban lm. Oncotarget. 2017 Oct 24;8(65):108451-108462. doi: 10.18632/oncotarget.21984. eCollection 2017 Dec 12. Oncotarget. 2017. PMID: 29312542 Free PMC article.
Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance.
Borque-Fernando Á, Rubio-Briones J, Esteban LM, Dong Y, Calatrava A, Gómez-Ferrer Á, Gómez-Gómez E, Gil Fabra JM, Rodríguez-García N, López González PÁ, García-Rodríguez J, Rodrigo-Aliaga M, Herrera-Imbroda B, Soto-Villalba J, Martínez-Breijo S, Hernández-Cañas V, Soto-Poveda AM, Sánchez-Rodríguez C, Carrillo-George C, Hernández-Martínez YE, Okrongly D. Borque-Fernando Á, et al. Among authors: esteban lm. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):84-90. doi: 10.1038/s41391-018-0074-5. Epub 2018 Aug 14. Prostate Cancer Prostatic Dis. 2019. PMID: 30108375
Are targeted prostate biopsies ready to replace systematic prostate biopsies?
Celma A, López R, Roche S, Planas J, Regis L, Placer J, Borque A, Esteban LM, de Torres I, Morote J. Celma A, et al. Among authors: esteban lm. Actas Urol Esp (Engl Ed). 2019 Dec;43(10):573-578. doi: 10.1016/j.acuro.2018.06.011. Epub 2019 Oct 31. Actas Urol Esp (Engl Ed). 2019. PMID: 31679807 English, Spanish.
Validation of a 2-gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening population.
Rubio-Briones J, Borque-Fernando A, Esteban LM, Mascarós JM, Ramírez-Backhaus M, Casanova J, Collado A, Mir C, Gómez-Ferrer A, Wong A, Aragón F, Calatrava A, López-Guerrero JA, Groskopf J, Schalken J, Van Criekinge W, Domínguez-Escrig J. Rubio-Briones J, et al. Among authors: esteban lm. Prostate. 2020 May;80(6):500-507. doi: 10.1002/pros.23964. Epub 2020 Feb 20. Prostate. 2020. PMID: 32077525
Role of PCA3 and SelectMDx in the optimization of active surveillance in prostate cancer.
Fiorella D, Marenco JL, Mascarós JM, Borque-Fernando Á, Esteban LM, Calatrava A, Pastor B, López-Guerrero JA, Rubio-Briones J. Fiorella D, et al. Among authors: esteban lm. Actas Urol Esp (Engl Ed). 2021 Jul-Aug;45(6):439-446. doi: 10.1016/j.acuroe.2020.10.013. Epub 2021 Jun 18. Actas Urol Esp (Engl Ed). 2021. PMID: 34148844 English, Spanish.
89 results